ANALYST RECOMMENDATIONS : AbbVie, Bristol-Myers, Dominion Energy, Pfizer, Walgreens Boots...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• AbbVie: Credit Suisse reinstated coverage with a recommendation of outperform. PT set to $170.
• Amgen: Credit Suisse reinstated coverage with a recommendation of underperform. PT set to $240.
• Bakkavor: HSBC downgrades from buy to hold targeting GBp 90.10.
• Bristol-Myers: Credit Suisse reinstated coverage with a recommendation of neutral. PT set to $78.
• Burberry: Jefferies maintains a Hold rating with a price target raised from GBp 1900 to GBp 2100.
• Dominion Energy:  Evercore ISI analyst Durgesh Chopra downgrades to inline from outperform. PT up 31% to $78.
• First Foods: Jefferies remains Buy with a price target raised from GBp 120 to GBp 130.
• Johnson & Johnson: Credit Suisse reinstated coverage with a recommendation of neutral. PT set to $170.
• Merck & Co: Credit Suisse reinstated coverage with a recommendation of outperform. PT set to $120.
• Pfizer: Credit Suisse reinstated coverage with a recommendation of outperform. PT set to $55.
• Virgin Money: Jefferies remains Buy with a price target reduced from GBp 258 to GBp 197.
• Walgreens Boots: J.P. Morgan raised its recommendation to overweight from neutral. PT up 4.7% to $42.